- Home
- AMRN vs ARAY Comparison
AMRN vs ARAY Comparison
Compare AMRN & ARAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMRN | ARAY |
|---|---|---|
| Founded | 1989 | 1990 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 304.3M | 55.2M |
| IPO Year | 1998 | 2006 |
Fundamental Metrics
Financial Performance| Metric | AMRN | ARAY |
|---|---|---|
| Price | $14.60 | $0.38 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $3.50 |
| AVG Volume (30 Days) | 55.7K | ★ 3.5M |
| Earning Date | 04-29-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 55.00 | ★ 87.50 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $181,104,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.26 | $4.58 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 39.22 | N/A |
| 52 Week Low | $11.42 | $0.25 |
| 52 Week High | $20.90 | $2.10 |
Technical Indicators
Market Signals| Indicator | AMRN | ARAY |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 51.92 |
| Support Level | $14.34 | $0.34 |
| Resistance Level | $15.39 | $0.48 |
| Average True Range (ATR) | 0.51 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 42.70 | 70.98 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.
About ARAY Accuray Incorporated
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.